Jefferies Underperform On AMAG￿ Pharmaceuticals ￿(AMAG)

by Roger Nachman, Benzinga Staff Writer
February 28, 2011 7:34 AM | 11 seconds read |
Jefferies & Co. has an Underperform rating on shares of AMAG� Pharmaceuticals �AMAG and a $12 price target. On Friday, shares of AMAG gained $1.06 to close at $18.30, a gain of 6.1%.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareJefferies & Co.Life Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!